MSOS Dec 2024 18.000 call
- Yahoo Finance Video
DEA sets date for marijuana rescheduling for after election
Drug Enforcement Administration (DEA) officials has set the date for a hearing to possibly reclassify marijuana to a Schedule 1 drug on December 2, after the 2024 presidential election. Cannabis stocks, including Curaleaf (CURLF), Tilray (TLRY), Green Thumb (GTBIF), Cresco Labs (CRLBF), and Verano Holdings (VRNOF), are sliding on this news. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan.
- Yahoo Finance
What marijuana reclassification means for the US cannabis industry
Curaleaf CEO Matt Darin said it was "a historic moment" for the cannabis industry following reports that the DEA is seeking to reschedule marijuana. Here are some of the implications for the weed industry.
- Zacks
Cannabis ETF (MSOS) Hits New 52-Week High
This Cannabis ETF hits a new 52-week high. Are more gains in store for this ETF?
